Please use this identifier to cite or link to this item:
Title: Ceramides and mitochondrial fatty acid oxidation in obesity
Author: Fucho Salvador, Raquel
Casals i Farré, Núria
Serra i Cucurull, Dolors
Herrero Rodríguez, Laura
Keywords: Obesitat
Carnitina palmitoïl-transferasa 1
Resistència a la insulina
Àcids grassos
Carnitine palmitoyltransferase I
Insulin resistance
Fatty acids
Issue Date: 21-Dec-2016
Publisher: The Federation of American Society of Experimental Biology
Abstract: : Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved in metabolic disorders such as obesity, diabetes, and cardiovascular disease. In addition, obesity causes a decrease in fatty acid oxidation (FAO), which contributes to lipid accumulation within the cells, conferringmore susceptibility to cell dysfunction. C16:0 ceramide, a specific ceramide species, has been identified recently as the principal mediator of obesity-derived insulin resistance, impaired fatty acid oxidation, and hepatic steatosis. In this review, we have sought to cover the importance of the ceramide species and their metabolism, the main ceramide signaling pathways in obesity, and the link between C16:0 ceramide, FAO, and obesity.¿Fucho, R., Casals, N., Serra, D., Herrero, L. Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB J. 31, 000-000 (2017).
Note: Versió preprint del document publicat a:
It is part of: The FASEB Journal , 2016, vol. 31, p. 1-10
Related resource:
ISSN: 0892-6638
Appears in Collections:Articles publicats en revistes (Bioquímica i Fisiologia)

Files in This Item:
File Description SizeFormat 
666372.pdf732.11 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.